DrugPatentWatch Database Preview
MELLARIL Drug Profile
» See Plans and Pricing
Which patents cover Mellaril, and when can generic versions of Mellaril launch?
Mellaril is a drug marketed by Novartis and is included in two NDAs.
The generic ingredient in MELLARIL is thioridazine. There are eighteen drug master file entries for this compound. Additional details are available on the thioridazine profile page.
Summary for MELLARIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Bulk Api Vendors: | 38 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,039 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | MELLARIL at DailyMed |
Recent Clinical Trials for MELLARIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Oxnard Foundation | Phase 0 |
| New Mexico Cancer Care Alliance | Phase 0 |
US Patents and Regulatory Information for MELLARIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | MELLARIL | thioridazine hydrochloride | CONCENTRATE;ORAL | 011808-012 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-009 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-016 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-017 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | CONCENTRATE;ORAL | 011808-018 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-011 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
